http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2753376-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4655b70cbfba352025a1d2393b449e77
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
filingDate 1996-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53bea500fede060bb5a00069a5cfce46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fba466aa29b2ca1a0ed87b653ec4d2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cafd8fc050b8d70a3969df8163c7c5e8
publicationDate 1998-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2753376-A1
titleOfInvention PHARMACEUTICAL COMPOSITIONS COMPRISING AMISULPRIDE AND THERAPEUTIC APPLICATIONS THEREOF
abstract Pharmaceutical composition, mainly intended for oral administration, comprising a lipophilic phase in which is dissolved, at least partially, at least one active principle consisting of amisulpride, one of its levorotatory and dextrorotatory isomers or a derivative of Amisulpride selected from its addition salts with pharmacologically acceptable acids, its quaternary ammonium salts, its oxides and their levorotatory and dextrorotatory isomers. Application in therapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2790388-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0051563-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019224375-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9956727-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9956727-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3081350-A1
priorityDate 1996-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423279168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44558878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456986878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2159
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456126543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426071153

Total number of triples: 41.